Valuation: Qlife Holding AB

Market Cap 3.2Cr 32.14L 28.74L 26.59L 24.07L 45.05L 31Cr 45.79L 1.27Cr 16Cr 1.21Cr 1.18Cr 51Cr P/E 2024
-0.26x
P/E 2025 -1.73x
Enterprise Value 4.5Cr 45.22L 40.43L 37.41L 33.87L 63.39L 43Cr 64.43L 1.78Cr 23Cr 1.7Cr 1.66Cr 71Cr EV / Sales 2024
222x
EV / Sales 2025 178x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day-5.78%
1 week-7.28%
Current month-25.43%
1 month-29.36%
3 months-47.48%
6 months-45.05%
Current year-63.24%
1 week 0.85
Extreme 0.85
1.56
1 month 0.85
Extreme 0.85
1.67
Current year 0.85
Extreme 0.85
3.09
1 year 0.85
Extreme 0.85
3.8
3 years 0.85
Extreme 0.85
179
5 years 0.85
Extreme 0.85
73,000
10 years 0.85
Extreme 0.85
1,20,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2019
Chief Executive Officer 59 11/10/2019
Director of Finance/CFO 60 01/11/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2021
Director/Board Member 52 01/01/2023
Chairman 61 21/03/2025
Date Insider Type Main position Quantity % Market Cap. Importance
14/06/23 Free

Chief Executive Officer

1,26,97,080 2.1166%
14/06/23
Qlife ApS
OthersCompany 4,06,30,656 6.7731%
13/06/23 Free

Chief Financial Officer

50,78,832 0.8466%
Change 5-day change 1-year change 3-year change Capi.($)
-5.78%-7.28%-52.33%-98.34% 32.23L
+0.41%-0.05%-18.22%+10.67% 18TCr
-0.95%+2.03%-20.78%+17.57% 12TCr
-1.01%+1.72%+0.25%+34.10% 12TCr
-3.42%+15.09%-44.71%+5.61% 9.33TCr
-0.36%-2.96%-1.82%+74.94% 6.32TCr
+0.04%+1.79%+13.52%+75.53% 5.57TCr
-2.00%+2.21%+4.23%-23.30% 5.42TCr
+1.59%+2.52%-11.99%+43.37% 4.41TCr
+0.03%+6.23%-4.20%-7.53% 3.4TCr
Average -1.13%+2.92%-13.60%+13.26% 7.58TCr
Weighted average by Cap. -0.70%+3.05%-12.74%+23.50%

Financials

2024 2025
Net sales 50T 5.02T 4.49T 4.16T 3.76T 7.04T 5L 7.16T 19.78T 2L 18.85T 18.45T 8L 3L 32.55T 29.1T 26.92T 24.38T 45.63T 30.96L 46.37T 1L 16.2L 1L 1L 51.28L
Net income -5.59Cr -56.17L -50.23L -46.47L -42.07L -78.75L -53Cr -80.04L -2.21Cr -28Cr -2.11Cr -2.06Cr -89Cr -2.06Cr -20.65L -18.47L -17.08L -15.47L -28.95L -20Cr -29.42L -81.32L -10Cr -77.5L -75.85L -33Cr
Net Debt 59.84L 6L 5L 5L 5L 8L 5.72Cr 9L 23.67L 2.99Cr 22.56L 22.08L 9.47Cr 1.3Cr 13.08L 11.7L 10.82L 10L 18.34L 12Cr 18.64L 51.51L 6.51Cr 49.1L 48.05L 21Cr
Projected Income Statement - Annual - Qlife Holding AB
Logo Qlife Holding AB
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Employees
2
Date Price Change Volume
26/26/26 SEK 1.044 -5.78% 55,545
23/26/23 SEK 1.108 +19.27% 4,15,408
22/26/22 SEK 0.9290 -7.10% 81,829
21/26/21 SEK 1.000 -9.75% 94,426
20/26/20 SEK 1.108 -1.60% 1,01,437

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Qlife Holding AB
  1. Stock Market
  2. Stocks
  3. QLIFE Stock